Higher or Lower Hemoglobin Transfusion Thresholds for Preterm Infants
dc.contributor.author | Kirpalani, Haresh | |
dc.contributor.author | Bell, Edward F. | |
dc.contributor.author | Hintz, Susan R. | |
dc.contributor.author | Tan, Sylvia | |
dc.contributor.author | Schmidt, Barbara | |
dc.contributor.author | Chaudhary, Aasma S. | |
dc.contributor.author | Johnson, Karen J. | |
dc.contributor.author | Crawford, Margaret M. | |
dc.contributor.author | Newman, Jamie E. | |
dc.contributor.author | Vohr, Betty R. | |
dc.contributor.author | Carlo, Waldemar A. | |
dc.contributor.author | D'Angio, Carl T. | |
dc.contributor.author | Kennedy, Kathleen A. | |
dc.contributor.author | Ohls, Robin K. | |
dc.contributor.author | Poindexter, Brenda B. | |
dc.contributor.author | Schibler, Kurt | |
dc.contributor.author | Whyte, Robin K. | |
dc.contributor.author | Widness, John A. | |
dc.contributor.author | Zupancic, John A.F. | |
dc.contributor.author | Wyckoff, Myra H. | |
dc.contributor.author | Truog, William E. | |
dc.contributor.author | Walsh, Michele C. | |
dc.contributor.author | Chock, Valerie Y. | |
dc.contributor.author | Laptook, Abbot R. | |
dc.contributor.author | Sokol, Gregory M. | |
dc.contributor.author | Yoder, Bradley A. | |
dc.contributor.author | Patel, Ravi M. | |
dc.contributor.author | Cotten, C. Michael | |
dc.contributor.author | Carmen, Melissa F. | |
dc.contributor.author | Devaskar, Uday | |
dc.contributor.author | Chawla, Sanjay | |
dc.contributor.author | Seabrook, Ruth | |
dc.contributor.author | Higgins, Rosemary D. | |
dc.contributor.author | Das, Abhik | |
dc.contributor.department | Pediatrics, School of Medicine | en_US |
dc.date.accessioned | 2023-03-20T14:00:28Z | |
dc.date.available | 2023-03-20T14:00:28Z | |
dc.date.issued | 2020-12-01 | |
dc.description.abstract | Background: Limited data suggest that higher hemoglobin thresholds for red-cell transfusions may reduce the risk of cognitive delay among extremely-low-birth-weight infants with anemia. Methods: We performed an open, multicenter trial in which infants with a birth weight of 1000 g or less and a gestational age between 22 weeks 0 days and 28 weeks 6 days were randomly assigned within 48 hours after delivery to receive red-cell transfusions at higher or lower hemoglobin thresholds until 36 weeks of postmenstrual age or discharge, whichever occurred first. The primary outcome was a composite of death or neurodevelopmental impairment (cognitive delay, cerebral palsy, or hearing or vision loss) at 22 to 26 months of age, corrected for prematurity. Results: A total of 1824 infants (mean birth weight, 756 g; mean gestational age, 25.9 weeks) underwent randomization. There was a between-group difference of 1.9 g per deciliter (19 g per liter) in the pretransfusion mean hemoglobin levels throughout the treatment period. Primary outcome data were available for 1692 infants (92.8%). Of 845 infants in the higher-threshold group, 423 (50.1%) died or survived with neurodevelopmental impairment, as compared with 422 of 847 infants (49.8%) in the lower-threshold group (relative risk adjusted for birth-weight stratum and center, 1.00; 95% confidence interval [CI], 0.92 to 1.10; P = 0.93). At 2 years, the higher- and lower-threshold groups had similar incidences of death (16.2% and 15.0%, respectively) and neurodevelopmental impairment (39.6% and 40.3%, respectively). At discharge from the hospital, the incidences of survival without severe complications were 28.5% and 30.9%, respectively. Serious adverse events occurred in 22.7% and 21.7%, respectively. Conclusions: In extremely-low-birth-weight infants, a higher hemoglobin threshold for red-cell transfusion did not improve survival without neurodevelopmental impairment at 22 to 26 months of age, corrected for prematurity. | en_US |
dc.eprint.version | Author's manuscript | en_US |
dc.identifier.citation | Kirpalani H, Bell EF, Hintz SR, et al. Higher or Lower Hemoglobin Transfusion Thresholds for Preterm Infants. N Engl J Med. 2020;383(27):2639-2651. doi:10.1056/NEJMoa2020248 | en_US |
dc.identifier.uri | https://hdl.handle.net/1805/31962 | |
dc.language.iso | en_US | en_US |
dc.publisher | Massachusetts Medical Society | en_US |
dc.relation.isversionof | 10.1056/NEJMoa2020248 | en_US |
dc.relation.journal | The New England Journal of Medicine | en_US |
dc.rights | Publisher Policy | en_US |
dc.source | PMC | en_US |
dc.subject | Anemia | en_US |
dc.subject | Cerebral Palsy | en_US |
dc.subject | Erythrocyte transfusion | en_US |
dc.subject | Low birth weight | en_US |
dc.subject | Newborn infant | en_US |
dc.subject | Vision disorders | en_US |
dc.subject | Neurodevelopmental disorders | en_US |
dc.title | Higher or Lower Hemoglobin Transfusion Thresholds for Preterm Infants | en_US |
dc.type | Article | en_US |